Micafungin has been found in drug studies to induce apoptosis in osteosarcoma cells and prevent epithelial–mesenchymal transition (EMT) in a USP7/AKT/GSK-3β pathway-dependent manner, exerting anti-tumor effects [89]. The gene discussed is AKT1; the disease is osteosarcoma.